Par Pharmaceutical, Inc. v. Twi Pharmaceuticals, Inc.

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ PAR PHARMACEUTICAL, INC., ALKERMES PHARMA IRELAND LIMITED, Plaintiffs-Appellants v. TWI PHARMACEUTICALS, INC., Defendant-Appellee ______________________ 2015-1880 ______________________ Appeal from the United States District Court for the District of Maryland in No. 1:11-cv-02466-CCB, Judge Catherine C. Blake. ______________________ JUDGMENT ______________________ DANIEL BROWN, Latham & Watkins LLP, New York, NY, argued for plaintiffs-appellants. Plaintiff-appellant Par Pharmaceutical, Inc., also represented by ROGER J. CHIN, GREGORY SOBOLSKI, San Francisco, CA; JONATHAN Y. ELLIS, GREGORY G. GARRE, MICHAEL J. GERARDI, Wash- ington, DC; JAMES PATRICK ULWICK, Kramon and Gra- ham, P.A., Baltimore, MD. MARYELLEN NOREIKA, Morris, Nichols, Arsht & Tun- nell LLP, Wilmington, DE, for plaintiff-appellant Alker- mes Pharma Ireland Limited. Also represented by JACK B. BLUMENFELD, JEREMY A. TIGAN; JAMES PATRICK ULWICK, Kramon and Graham, P.A., Baltimore, MD. DONALD J. MIZERK, Husch Blackwell LLP, Chicago, IL, argued for defendant-appellee. Also represented by PHILIP DALE SEGREST, JR., JOHN A. SHOLAR, JR. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (O’MALLEY, PLAGER, and WALLACH, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT December 15, 2015 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court